Christina C. Smith - Concepedia

Author

Christina C. Smith

Bristol-Myers Squibb (United States)

Also Known As

C.C. Smith, Christina C Smith, Christina C. Smith, Christina Cognata Smith, Christina Smith

Publications

318

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)Bioanalytical Systems (United States)

About

Christina C. Smith is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	168
2	Pharmacology	4	4	133
3	Neurology	3	3	56
4	Health Sciences	1	1	10
5	Neuroscience	1	1	10

Christina C. Smith

Publications

274

Citations

H-Index

Page 1

	Year	Citations
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study of the Oral γ-Secretase Inhibitor BMS-708163 (Avagacestat): Tolerability Profile, Pharmacokinetic Parameters, and Pharmacodynamic Markers Gary Tong, Junsheng Wang, Oleksandr Sverdlov, Clinical Therapeutics Single-ascending Dose StudyTherapeutic Drug MonitoringPharmacologyClinical TrialsPharmacokinetic Parameters	2012	65
A Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Avagacestat (BMS-708163) in Healthy Young and Elderly Subjects Randy Dockens, Junsheng Wang, Lorna Castaneda, Clinical Pharmacokinetics Drug SafetyPharmacological StudyElderly SubjectsPharmacologyClinical Trials	2012	47
Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3 multicenter, randomized, double-blind, placebo-controlled studies. Neil A. Swanson, Christina C. Smith, Mandeep Kaur, PubMed	2013	43
Effects of Single Doses of Avagacestat (BMS-708163) on Cerebrospinal Fluid Aβ Levels in Healthy Young Men Gary Tong, Lorna Castaneda, Junsheng Wang, Clinical Drug Investigation Neurobiology Of DiseaseAlzheimer's DiseaseSingle DosesCerebrospinal FluidBrain-immune Interaction	2012	35
Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers D. Alexander Oh, Neha Parikh, Varun Khurana, Clinical Pharmacology Advances and Applications	2017	26
Bioavailability study of dronabinol oral solution versus dronabinol capsules in healthy volunteers Neha Parikh, William G. Kramer, Varun Khurana, Clinical Pharmacology Advances and Applications	2016	22
A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ‐secretase inhibitor avagacestat Gary Tong, Junsheng Wang, Oleksandr Sverdlov, British Journal of Clinical Pharmacology	2012	15
P3‐303: A placebo‐controlled, ascending, multiple‐dose study to evaluate the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of BMS‐708163 in healthy young and elderly subjects Junsheng Wang, Lorna Castaneda, Alex Sverdlov, Alzheimer s & Dementia Elderly SubjectsPharmacotherapyPhysiologically-based Pharmacokinetic ModelingPharmacodynamic ModelingPre-clinical Pharmacology	2010	11
O3‐07‐07: A study to evaluate the effects of single oral doses of BMS‐708163 in the cerebrospinal fluid of healthy young men Gary Tong, Lorna Castaneda, Junsheng Wang, Alzheimer s & Dementia Neurochemical BiomarkersPharmacotherapySingle Oral DosesHealthy Young MenNeurobiology Of Disease	2010	10

Page 1